D-238-2013 Class III Terminated
FDA drug recall D-238-2013 was initiated by Dr. Reddy'S Laboratories on Mar 19, 2013 and is designated Class III. Reason for recall: Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details. The recall status is terminated (terminated Feb 6, 2014). Affected quantity: 117,546 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 10, 2013
- Initiation Date
- Mar 19, 2013
- Termination Date
- Feb 6, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 117,546 bottles
Product description
Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepally - 500 090 India; NDC 55111-180-15.
Reason for recall
Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.
Distribution pattern
Nationwide and Puerto Rico.
Code information
Lot #: C208625, C208984, C209113, C209369, Exp 09/15; and C209680, Exp 10/15.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-238-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026